Oxolife will present its newest evidences on OXO-001 in fertility and embryo implantation in the American Society for … [Read more...] about OXOLIFE presents the latest results in the ASRM21
OXOLIFE IS PRESENT IN THE 4YFN – MWC
Today, Oxolife founders Agnès Arbat and Ignasi Canals are in the international event 4YFN - 4 Years from Now, hold in … [Read more...] about OXOLIFE IS PRESENT IN THE 4YFN – MWC
OXOLIFE has two accepted communications in the ESHRE Annual Meeting
The European Society of Human Reproduction and Embryology (ESHRE) has accepted our second communication for its … [Read more...] about OXOLIFE has two accepted communications in the ESHRE Annual Meeting
Oxolife has been recognized as an innovative SME
The Ministry of Science and Innovation has awarded us the seal of small and medium-sized innovative company. From now … [Read more...] about Oxolife has been recognized as an innovative SME
The phase II clinical trial protocol and documents have been submitted!
Today we have a BIG new! We want to announce that the protocol and documents for the phase II clinical trial of … [Read more...] about The phase II clinical trial protocol and documents have been submitted!
We are Catalonia BioHT!
The video presentation of Oxolife as a new member of CataloniaBio Health Tech has already come to light. We are very … [Read more...] about We are Catalonia BioHT!
OXOLIFE will participate in the ESHRE 37th Annual Meeting
At the end of June, the European Society of Human Reproduction and Embryology (ESHRE) organizes its 37th Annual Meeting … [Read more...] about OXOLIFE will participate in the ESHRE 37th Annual Meeting
OXOLIFE AND IBEC START AN STRATEGIC ALLIANCE TO STUDY OXO-001 IMPLANTATION ACTIVITY
Fresh news! Today it has been published in La Vanguardia the collaboration between OXOLIFE and the Open Innovation … [Read more...] about OXOLIFE AND IBEC START AN STRATEGIC ALLIANCE TO STUDY OXO-001 IMPLANTATION ACTIVITY
BIOTECH COMPANY OXOLIFE AND UNIVERSITY OF CORDOBA ARE TESTING A NEW DRUG TO IMPROVE FERTILITY IN WOMEN WITH POLYCYSTIC OVARY
Oxolife has established a collaboration with the Energy Balance, Puberty and Reproductive Health Group of the University … [Read more...] about BIOTECH COMPANY OXOLIFE AND UNIVERSITY OF CORDOBA ARE TESTING A NEW DRUG TO IMPROVE FERTILITY IN WOMEN WITH POLYCYSTIC OVARY
OXOLIFE RECEIVES SEAL OF EXCELLENCE FROM THE EUROPEAN COMMISSION
OXOLIFE is celebrating. The European Commission has awarded us with the “Seal of Excellence” for our … [Read more...] about OXOLIFE RECEIVES SEAL OF EXCELLENCE FROM THE EUROPEAN COMMISSION